NEW YORK, April 03, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of USANA Health Sciences, Inc. ("USANA") (NYSE:USNA) between March 14, 2014 and February 7, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of Utah. To get more information go to:
http://www.zlk.com/pslra/usana-health-sciences-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts, including that: (i) the Company's BabyCare Ltd. subsidiary had engaged in improper reimbursement practices in China; (ii) these practices constituted violations of the Foreign Corrupt Practices Act; (iii) as such, the Company’s China revenues were in part the product of unlawful conduct and unlikely to be sustainable; (iv) the foregoing conduct was likely to subject the Company to significant regulatory scrutiny; and (v) as a result of the foregoing, USANA’s public statements were materially false and misleading at all relevant times
On February 7, 2017, post-market, USANA disclosed that “[t]he Company is voluntarily conducting an internal investigation of its China operations, BabyCare Ltd. The investigation focuses on compliance with the Foreign Corrupt Practices Act . . . and certain conduct and policies at BabyCare, including BabyCare's expense reimbursement policies.”
If you suffered a loss in USANA you have until April 14, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift
SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 



